Mimedx (MDXG) Non Operating Income (2014 - 2026)
Mimedx's (MDXG) quarterly Non Operating Income came in at -$168000.0 in Q1 2026, down 15.86% year-on-year from -$199672.1 in Q1 2025, and up 9.68% quarter-over-quarter from -$186000.0 in Q4 2025.
Mimedx (MDXG) Non Operating Income (2014 - 2026) Analysis & Trends
Mimedx has disclosed Non Operating Income across 12 years of filings, most recently posting -$168000.0 for Q1 2026.
- Non Operating Income for Q1 2026 came in at -$168000.0, down 15.86% year-over-year; the trailing twelve-month figure through Mar 2026 was -$581000.0 (up 4.91% YoY), and the FY2025 annual result was -$558000.0, up 1.24% from the prior year.
- Non Operating Income came in at -$168000.0 for Q1 2026 at Mimedx, up from -$186000.0 in the prior quarter.
- In the past five years, Non Operating Income ranged from a high of $16000.0 in Q4 2023 to a low of -$237000.0 in Q2 2024.
- The 5-year median for Non Operating Income is -$100000.0 (2024), against an average of -$94214.3.
- Across the five-year window, Non Operating Income surged 633.33% in 2023 and slumped 5050.0% in 2024, its largest moves.
- Mimedx's Non Operating Income stood at -$3000.0 in 2022, then soared by 633.33% to $16000.0 in 2023, then slumped by 1400.0% to -$208000.0 in 2024, then advanced by 10.58% to -$186000.0 in 2025, then climbed by 9.68% to -$168000.0 in 2026.
- The last three Non Operating Income figures came in at -$168000.0 (Q1 2026), -$186000.0 (Q4 2025), and -$126000.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Op. Inc. (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | 5.75 Mn |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | - |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | 444,000.00 |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | - |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | 9.35 Mn |
| 10 | Mimedx | 546.28 Mn | 386.51 Mn | 41.62 Mn | -168,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -168,000.00 |
| Dec 31, 2025 | -186,000.00 |
| Sep 30, 2025 | -126,000.00 |
| Jun 30, 2025 | -101,000.00 |
| Mar 31, 2025 | -145,000.00 |
| Dec 31, 2024 | -208,000.00 |
| Sep 30, 2024 | -21,000.00 |
| Jun 30, 2024 | -237,000.00 |
| Mar 31, 2024 | -99,000.00 |
| Dec 31, 2023 | 16,000.00 |
| Sep 30, 2023 | -11,000.00 |
| Jun 30, 2023 | -32,000.00 |
| Mar 31, 2023 | 2,000.00 |
| Dec 31, 2022 | -3,000.00 |
| Dec 31, 2021 | -20,000.00 |
| Jun 30, 2021 | -3,000.00 |
| Dec 31, 2020 | -1,000.00 |
| Sep 30, 2020 | 1,000.00 |
| Jun 30, 2020 | -9,000.00 |
| Mar 31, 2020 | 6,000.00 |